spacer gif spacer gif spacer gif spacer gif ARCHIVE ANNOUNCEMENT! spacer gif
QUICK SEARCH:   [advanced]


spacer gif
     Home     Help     Feedback     Subscriptions     Archive     Search     Table of Contents    

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mackie, E. J.
Right arrow Articles by Bruns, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mackie, E. J.
Right arrow Articles by Bruns, C.

Development, Vol 110, Issue 4 1233-1239, Copyright © 1990 by Company of Biologists

JOURNAL ARTICLES

Somatostatin receptors are restricted to a subpopulation of osteoblast-like cells during endochondral bone formation

EJ Mackie, U Trechsel and C Bruns
Preclinical Research, Sandoz Pharma Ltd., Basel, Switzerland.

Specific binding sites for the peptide hormone somatostatin have previously been demonstrated in long bones from neonatal rats. In the present study, the distribution of somatostatin receptors during embryonic bone formation has been investigated using the stable radioiodinated somatostatin analogue, SDZ 204-090. Somatostatin receptors in rat long bones were first detectable at the time of invasion of the cartilage model by osteogenic cells. Initially, receptors were detectable throughout the region occupied by osteogenic cells. As bone growth proceeded, however, receptors were restricted to the region of most recent invasion of the hypertrophic cartilage, where osteoid had not yet been deposited. In vivo labelling studies in neonatal rats were carried out to identify the cells bearing somatostatin receptors. Receptors were present in a restricted region of the metaphysis, immediately adjacent to the hypertrophic cartilage. Chondrocytes, osteoclasts, and mature osteoblasts were not labelled by the radioligand. The labelled cells were often apposed to remnants of cartilage matrix and stained positively for the osteoblast marker, alkaline phosphatase. Thus the cells with specific somatostatin-binding sites were probably osteoblast precursor cells. Specific binding was detectable in all endochondral bones examined, including those of the skull, but no specific binding was found in the membrane bones of the skull. These data suggest that somatostatin is involved in the regulation of osteoblast differentiation during endochondral bone formation.


This article has been cited by other articles:


Home page
 J. Clin. Endocrinol. Metab.Home page
J. A. Clowes, H. C. Allen, D. M. Prentis, R. Eastell, and A. Blumsohn
Octreotide Abolishes the Acute Decrease in Bone Turnover in Response to Oral Glucose
J. Clin. Endocrinol. Metab., October 1, 2003; 88(10): 4867 - 4873.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
J. Zapf, M. Gosteli-Peter, G. Weckbecker, E. B. Hunziker, and M. Reinecke
The Somatostatin Analog Octreotide Inhibits GH-Stimulated, But Not IGF-I-Stimulated, Bone Growth in Hypophysectomized Rats
Endocrinology, August 1, 2002; 143(8): 2944 - 2952.
[Abstract] [Full Text] [PDF]


© The Company of Biologists Ltd 1990